Skip to main content

Pharm Exam 1 Review Lecture notes 1-2

Page 1

lOMoARcPSD|11700591

The Nursing Process o An organizational framework for the practice of nursing.  Steps:  Assessment  Data collection, review & analysis  Medication profile  Diagnosis  Used to communicate and share info about the patient and the patient experience  Common diagnoses:  Deficient knowledge  Risk for injury  noncompliance  Planning  Goals - objective, measurable, and realistic with an established time period for achievement of the outcomes that are specifically stated in the outcome criteria  Outcome Criteria - concrete description of patient goals  Implementation  Initiation and completion of specific nursing actions as defined by the nursing diagnoses, goals and outcome criteria  Follow the 6 rights of med administration  Right drug, dose, time, route, patient & documentation  Evaluation  Ongoing part of the nursing process  Determining the status of the goals and outcomes of care  Monitor the patients response to drug therapy

Subjective Data o Includes all spoken information shared by the patient o Such as:  Complaints  Problems  Or stated needs

Objective Data o Includes information available through senses, such as what is seen, felt, heard, and smelled. o Among the sources of data are:  The chart  Lab results  Report of diagnostic procedures  Physical assessment  Examination findings o Examples:  Age  Height


lOMoARcPSD|11700591

   

Weight Allergies Med profile Health history

Pharmacokinetics - the study of what the body does to the drug (think MOVEMENT) o Four major pharmacokinetic processes  Absorption  Bioavailability  First pass effect - the initial metabolism in the liver of a drug absorbed from the gastrointestinal tract before the drug reaches systemic circulation through the bloodstream  Different routes  Distribution  Transport of a drug by the bloodstream to its site of action  Albumin is the most common blood protein & carries the majority of protein-bound drug molecules  Metabolism (Biotransformation)  Biochemical alteration of a drug into an inactive metabolite, more soluble compound, more potent active metabolite, or a less active metabolite.  Excretion  Elimination of drugs from body  Renal Excretion - Kidneys are a primary source of excretion o Half-life - time required for 50% of a given drug to be removed from body

Pharmacodynamics - the study of what the drug does to the body o Mechanism of drug actions in living tissues o Therapeutic effect o Mechanism of action (MOA)

Lifespan Considerations o Fetus  Drugs cross the placenta by diffusion  FDA has implemented pregnancy safety categories o Infants (Neonatal & Pediatric)  Breastfed infants are at risk for exposure to drugs consumed by the mother  Consider risk-benefit ratio  Pharmacokinetics  Absorption  Gastric pH less acidic until 1-2 yr old  Gastric emptying slowed  IM absorption faster & irregular  Distribution  Greater total body water = lower fat content  Decreased level of protein binding  Immature BBB - more drugs enter brain  Metabolism


lOMoARcPSD|11700591

 

o

Immature liver - doesn’t produce enough microsomal enzymes Older children may have increased metabolism, requiring higher doses than infants  Excretion  Kidney immaturity affects glomerular filtration rate and tubular secretion  Decreased perfusion rate of the kidneys may reduce excretion of drugs  Skin is thin & permeable  Stomach lacks acid to kill bacteria  Lungs have weaker mucus barriers  Body temps less regulated - dehydration easily  Liver & kidneys immature, impairing drug metabolism & excretion Older Adults  High use of meds  Polypharmacy  Noncompliance/nonadherence  Increased incidence of chronic illnesses  Sensory and motor deficits  Pharmacokinetics  Absorption  Gastric pH less acidic  Gastric emptying slowed  Movement through GI slowed bc of decreased muscle tone and activity  Blood flow to GI tract reduced  Absorptive surface of GI slowed  Distribution  Lower total body water percentages  Increased fat content  Decreased production of proteins by liver = decreased protein binding of drugs  Metabolism  Aging liver produces fewer enzymes  Reduced blood flow to liver  Excretion  Decreased glomerular filtration rate  Decreased number of nephrons

Cultural Considerations o Influence of ethnicity on genetics and drug response o Varying drug responses in different racial or ethnic groups o Health beliefs and practices o Barriers to adequate health care for the culturally diverse US pop  Language, poverty, access, pride, and beliefs regarding med practices  Medications may also have a different meaning to different cultures


Turn static files into dynamic content formats.

Create a flipbook